Journal of Undergraduate Research
Volume 6, Issue # - Month Year
Refolding and Purification of “short” recombinant human Cathepsin D and Variants
Ambar Patel
ABSTRACT
Human cathepsin D (hCatD) is an aspartic peptidase synthesized at neutral pH as an inactive zymogen. Upon acidification, it is activated into its mature form through a series of intramolecular processing events. High-resolution X-ray crystal structures for both an active low pH, (pH 5.1) and an inactive high pH (pH 7.5) forms have been determined in an effort to design selective inhibitors for CatD (Lee et al., 1998). Based on the crystal structure, the hydroxyl group of tyrosine 10 (Y10) forms a hydrogen bond with the ionized catalytic carboxylate residue of aspartate 33 (Asp33), thus stabilizing the inactive form. We hypothesize that changing Y10 to phenylalanine (F) should favor the open conformation of our enzyme since phenylalanine cannot hydrogen bond with the catalytic carboxylate of Asp33. Site-directed mutagenesis was performed on “short” recombinant pseudocathepsin D to create the Y10F variant. The enzyme was purified by affinity chromatography followed by an ion exchange chromatography yielding purified mature enzyme. Additionally, refolding and pH experiments were performed with wild type and variants in order to optimize the purification yield. [Supported by NIH grant DK18865]
INTRODUCTION
Cathepsin D (CatD) is a member of the pepsin family of aspartic peptidases. Aspartic peptidases are endopeptidases, consisting of two aspartic acid residues that catalyze peptide bond hydrolysis through a general base catalyzed mechanism. A low pH optimum for catalytic activity is an important characteristic for these lysosomal enzymes. However, it has also been detected in other places including the cytosol and the extracellular space. In the extracellular space where pH is more neutral, it has been implicated in pathological processes such as inflammation, tumor progression, formation of metastases, and apoptosis (Leto et al., 1992; Mignatti and Rifkin, 1993). These findings are interesting in light of the acidic pH optimum of Cathepsin D.
To gain more insight on the role of CatD at more neutral pH, Lee and colleagues solved the structure at a high pH. They proposed a reversible, pH-dependent conformational change from a low pH (CatDlo), “open” and active conformation, to a high pH (CatDhi), “closed”, inactive conformation (1998). Structural comparison of CatDhi and CatDlo reveal significant conformational differences. An increase in pH induces a set of conformational changes that results in the relocation of the N-terminal segment into the active site where both catalytic aspartates are likely ionized. Additionally, the positively charged Nitrogen atom of Lysine 8 (K8) along with the hydrogen bond formed with the hydroxyl group of Y10 form interactions with the ionized catalytic aspartate acid residues to stabilize the inactive form. Reactivation due to a decrease in pH can occur due to protonation of one of the two catalytic aspartates, thus weakening electrostatic interactions and hydrogen bonds between the catalytic aspartates and Y10, respectively.
The goal of this project was to test the significance of hydrogen bonding between Y10 and Asp 33 in stabilizing the inactive form of the enzyme. The recombinant model, “short” pseudocathepsin D (rHuCatD) used to test our hypothesis is kinetically similar to the mature enzyme (Beyer and Dunn, 1996). By mutating the Y10 residue in “short” rHuCatD to phenylalanine (F), we expect the variant Y10F to exhibit an open conformation due to its inability to hydrogen bond with the catalytic carboxylate of Asp33.
MATERIALS AND METHODS
Mutagenesis
The gene encoding enzyme “short” rHuCatD obtained from Brian Beyer (1996) was mutated using the Quik-changeTM Site Directed Mutagenesis Kit from Stratagene (La Jolla, CA) to make the variant, Y10F. Shown in Table 1 is the primer and its reverse complement used to introduce the point mutation.
| Table 1 |
|||||||||||||||||||||||||||||||||||||||||
| Primer Sequence | Desired Mutation | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5' CCCATTCCCGAGGTGCTCAAGAACTTCATGGACC 3' | Tyr10Phc | ||||||||||||||||||||||||||||||||||||||||
| 3' GGGTAAGGGCTCCACGAGTTCTTGAAGTACCTG 5' | Tyr10Phc
ExpressionThe protocol of Chen et al. (1991) was modified as follows
in order to express and purify the variant. A 1:50 dilution of an overnight
culture grown in M9 media (10 mg/mL thiamine, 0.5% casamino acids, 0.2%
glucose) containing 50 mg/L ampicillin was made into LB media containing
50 mg/L ampicillin. As soon as the mixture was grown to an OD600
of 0.5, IPTG was added to give a final concentration of 0.5 mM. Aliquots
were taken before adding IPTG at 0, 1, 2, and 3 hours intervals, and
were analyzed by SDS-PAGE and Coomassie Blue staining in order to observe
a time-dependent increase in expression. The cells were pelleted by
centrifugation and resuspended in 4.2 mLs of 50 mM Tris-HCl pH 7.4,
150 mM NaCl and 1 mM MgCl2 (buffer A) per gram of cells.
Following the addition of 80 Kunitz units of Dnase per mL of suspension,
the cells were lysed twice through a French Pressure Cell. The resulting
lysate was layered over 27% sucrose and centrifuged in order to isolate
inclusion bodies. The inclusion bodies were resuspended in buffer A
containing 1% Triton X-100 and pelleted again through the sucrose cushion.
The pellet weight was measured and the inclusion bodies were frozen
at –80°C. To recover the active enzyme, the inclusion bodies were
resolubilized by rapid dilution following previously reported procedures
(Conner and Richo, 1992; Scarborough et al., 1993; Beyer and Dunn, 1996).
Inclusion bodies were solubilized and reduced at a concentration of
2 mg/mL in 50 mM CAPS pH 10.7, 50 mM _-mercaptoethanol, and 8 M urea.
The resolubilized solution was stirred for 30 minutes at 25°C and
was diluted 100 fold by dropwise addition into filtered 10 mM Tris-HCl
pH 8.7 to a final concentration of 20 µg/mL. After 4 hours, oxidized
glutathione was added to the refolding solution and the variant was
allowed to refold for a pre-determined optimum refolding time. The refolded
material was then activated by acidification with formic acid to pH
3.7. Refolding time-course and activation-time course experiments were
performed by removing aliquots from the refolding and activated material
respectively, and monitoring for emergence of enzymatic activity. The activated protein solution was applied to a C 16/20
affinity column (Amersham-Pharmacia) containing 1 mL of resuspended
pepstatinyl-agarose (Huang et al., 1979). The column was then washed
with at least 5 mLs of 0.01 M sodium formate pH 3.7, 0.4 M NaCl, 0.05%
Brij-35. It was eluted with cold 20 mM Tris-HCl pH 8.0, 0.4 M NaCl and
0.5% Brij 35 and fractions were analyzed for catalytic activity. The
fractions exhibiting activity were pooled and dialyzed against 4 L of
10 mM Tris-HCl pH 8.0 overnight at 4°C to desalt. Ion-exchange chromatography
was used to purify the mature form of the enzyme. A 1 mL HiTrap Q Sepharose
HP (Amersham Pharmacia), an anion exchanger, was equilibrated with 10
mM Tris-HCl pH 8.0 (buffer A). The desalted material was then applied
to the column at a flow rate of 1 mL/min. The column was washed with
buffer A and the mature protein was eluted with a salt gradient of 0-60
mM. Enzyme catalyzed hydrolysis of a fluorogenic substrate
was spectrofluorometrically monitored on a PerSeptive Biosystems CytoFluor
Series 4000/TC Multi-Well Plate Reader. Samples were excited at 360
nm and emission was monitored at 460 nm. Enzyme was preincubated for 10 minutes at 37°C in
the following 100 mM buffers: glycine-HCl pH 2.0-3.0; sodium formate
pH 3.75; sodium acetate pH 4.5; MES pH 5.5-7.0; Tris-HCl pH 8.3-9.3;
CAPS pH 10.7-11.7. After 10 minutes, pH was recorded and the enzyme
was added to 0.2 M sodium formate pH 3.7 at 37°C for an additional
3 minutes. It was then added to 30 _M substrate and enzymatic activity
was monitored. The final pH was recorded for all points.
Purification of Cat D and variants was achieved by expression in E.
coli, however, the protein was deposited into insoluble inclusion
bodies. Approximately 1 gram weight of inclusion body pellet was harvested
from a 1 L over-expression. SDS-PAGE analysis showed a time-dependent
increase in expression of the target protein (~40kDa) after addition
of IPTG (Figure 1). Since the enzyme was synthesized
as an inactive proenzyme, upon acidification and after a series of purification
steps, the mature enzyme was obtained (Figure 4). First,
affinity chromatography was used to purify the variant from the activated
refolding mixture (Figure 2). An ion-exchange chromatography
was included to purify the mature form of the enzyme from the post affinity
purification (Figure 3). Figure 4. Silver stained SDS-PAGE depicting
purification of Y10F. The far left lane corresponds to molecular weight
markers. Lane #3 represents full length Y10F from the refolding mixture.
Lane #2 shows the pepstatinly-agarose purification. Lane #1 illustrates
the DEAE ion-exchange for Y10F yielding the mature form of the enzyme. Figure 5. Refolding time-course experiment
for recombinant “short” pseudocathepsin D and its variants. Figure 6. Activation time-course experiment
for recombinant “short” pseudocathepsin D and its variants.
Figure 7. Activity of WT and variants after
optimal refolding and activation. Figure 8. pH dependent refolding for D187R
(red), E180Q (green), and E5QE180Q (black). Refolding of D187R was
at pH 10.5, E180Q at pH 8.7 and E5QE180Q at pH 11.0. Figure 9. pH-dependent stability assay for
Y10F and WT. WT is plotted as closed squares; Y10F open squares. Activity
measured from cleavage of fluorogenic substrate. Figure 10. Refolding time course assay for
WT showing the effect of addition of 20% glycerol.
Since the refolding step was very inefficient with about
a 1% recovery of the active material (Beyer and Dunn, 1996), parameters
such as amount of affinity resin and flow rate of affinity chromatography
were tested. Additionally, glycerol was added and pH of the refolding
mixture was varied in order to optimize the refolding process. This study allowed us to determine optimal refolding
conditions for Y10F and other variants. Our data showed substantial
decrease in the amount of recovered active material compared to WT.
Refolding and activation time-course experiments enabled us to optimize
the purification yield for WT and variant enzymes. The data obtained
from this study provided valuable information that enabled further kinetic
studies. Sophisticated experiments such as pH-dependent Michaelis-Menten
kinetics, intrinsic tryptophan fluorescence experiments, and N-terminal
sequencing for Y10F were performed by Nathan Goldfarb in Dr. Dunn’s
laboratory at the University of Florida. These studies revealed that
Y10F, in fact exhibited a conformational equilibrium shift to the more
open, “active” form of the enzyme. This indicated that the
hydrogen bonding interaction between Y10 and Asp 33 is a crucial interaction
that stabilizes the closed, high pH form of the enzyme. However, additional
studies need to be done to address the role of the Lys 8 - Asp 33 interaction
in this pH dependent conformational change. Beyer BM, Dunn BM. 1996. Self-activation of recombinant
human lysosomal procathepsin D at a newly engineered cleavage junction,
"short" pseudocathepsin D. J Biol Chem 271:15590-15596. Back to the Journal of Undergraduate
Research | ||||||||||||||||||||||||||||||||||||||||










